5448
P. K. Sasmal et al. / Bioorg. Med. Chem. Lett. 20 (2010) 5443–5448
10. Ludwig, D. S.; Tritos, N. A.; Mastaitis, J. W.; Kulkarni, R.; Kokkotou, E.; Elmquist,
J.; Lowell, B.; Flier, J. S.; Maratos-Flier, E. Journal Clin. Invest. 2001, 107, 379.
11. (a) Qu, D. Q.; Ludwig, D. S.; Gammeltoft, S.; Piper, M.; Pelleymounter, M. A.;
Cullen, M. J.; Mathes, W. F.; Przypek, J.; Kanarek, R.; Maratos-Flier, E. Nature
1996, 380, 243; (b) Mizuno, T. M.; Kleopoulos, S. P.; Bergen, H. T.; Roberts, J. L.;
Priest, C. A.; Mobbs, C. V. Diabetes 1998, 47, 294; (c) Hanada, R.; Nakazato, M.;
Matsukura, S.; Murakami, N.; Yoshimatsu, H.; Sakata, T. Biochem. Biophys. Res.
Commun. 2000, 268, 88.
23. Goss, J. M.; Schaus, S. E. Journal Org. Chem. 2008, 73, 7651.
24. Becker, O. M.; Dhanoa, D. S.; Marantz, Y.; Chen, D.; Shacham, S.; Cheruku, S.;
Heifetz, A.; Mohanty, P.; Fichman, M.; Sharadendu, A.; Nudelman, R.;
Kauffman, M.; Noiman, S. Journal Med. Chem. 2006, 49, 3116.
25. Characterization data of 27a: IR: 3400–2800 (br), 2930, 1678, 1610, 1510, 1227,
746 cmÀ1 1H NMR (CDCl3, 400 MHz): d 7.76 (d, J = 7.8 Hz, 1H), 7.50–7.48 (m,
;
2H), 7.37–7.19 (m, 7H), 7.06 (d, J = 7.8 Hz, 1H), 6.94 (d, J = 7.8 Hz, 1H), 3.30–
3.27 (m, 2H), 2.81 (t, J = 7.4 Hz, 2H), 2.68 (br s, 1H), 2.61–2.54 (m, 2H), 2.39–
2.35 (m, 2H), 2.16 (s, 3H), 2.04 (br s, 1H), 1.87 (br s, 3H), 1.25 (br s, 2H), 0.88-
084 (m, 2H); ESMS: m/z 485.4 (M+1).
12. Shimada, M.; Tritos, N. A.; Lowell, B. B.; Flier, J. S.; Maratos-Flier, E. Nature 1998,
396, 670.
13. (a) Chen, Y.; Hu, C.; Hsu, C.-K.; Zhang, Q.; Bi, C.; Asnicar, M.; Hsiung, H. M.; Fox,
N.; Slieker, L. J.; Yang, D. D.; Heiman, M. L.; Shi, Y. Endocrinology 2002, 143,
2469; (b) Marsh, D. J.; Weingarth, D. T.; Novi, D. E.; Chen, H. Y.; Trumbauer, M.
E.; Chen, A. S.; Guan, X.-M.; Jiang, M. M.; Feng, Y.; Camacho, R. E.; Shen, Z.;
Frazier, E. G.; Yu, H.; Metzger, J. M.; Kuca, S. J.; Shearman, L. P.; Gopal-Truter, S.;
MacNeil, D. J.; Strack, A. M.; MacIntyre, D. E.; Van der Ploeg, L. H. T.; Qian, S.
Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 3240.
14. Borowsky, B.; Durkin, M. M.; Ogozalek, K.; Marzabadi, M. R.; DeLeon, J.; Lagu,
B.; Heurich, R.; Lichtblau, H.; Shaposhnik, Z.; Daniewska, I.; Blackburn, T. P.;
Branchek, T. A.; Gerald, C.; Vaysse, P. J.; Forray, C. Nat. Med. 2002, 8, 825.
15. Takekawa, S.; Asami, A.; Ishihara, Y.; Terauchi, J.; Kato, K.; Shimomura, Y.; Mori,
M.; Murakoshi, H.; Kato, K.; Suzuki, N.; Nishimura, O.; Fujino, M. Eur. J.
Pharmacol. 2002, 438, 129.
26. Altman, R. A.; Koval, E. D.; Buchwald, S. L. Journal Org. Chem. 2007, 72,
6190.
27. (a) Jones, R. G. Journal Am. Chem. Soc. 1951, 73, 5168; (b) Musser, J. H.; Hudec, T.
T.; Bailey, K. Synth. Commun. 1984, 14, 947.
28. Receveur, J.-M.; Bjurling, E.; Christensen, A.; Högberg, T. PCT WO2006010446.
29. Eastwood, P. R. Tetrahedron Lett. 2000, 41, 3705.
30. Glennon, R. A.; Raghupathi, J. R.; Bartyzel, P.; Teitler, M.; Leonhardt, S. Journal
Med. Chem. 1992, 35, 734.
31. Lin, N.-H.; Xia, P.; Kovar, P.; Park, C.; Chen, Z.; Zhang, H.; Rosenberg, S. H.;
Sham, H. L. Bioorg. Med. Chem. Lett. 2006, 16, 421.
32. Tasneem Ali, M. M.; Rajanna, K. C.; Saiparakash, P. K. Synth. Commun. 2001, 31,
1123.
33.
[
125I]-MCH binding was performed by incubating membranes from CHO-
16. (a) McBriar, M. D.; Kowalski, T. J. Annu. Rep. Med. Chem. 2005, 40, 119; (b) Dyke,
H.; Ray, N. C. Expert Opin. Ther. Pat. 2005, 15, 1303; (c) Shi, Y. Peptides 2004, 25,
1605; (d) Browning, A. Expert Opin. Ther. Pat. 2004, 14, 313; (e) Kowalski, T. J.;
McBriar, M. D. Expert Opin. Invest. Drugs 2004, 13, 1113.
K1 cells stably expressing hMCHR1 with SPA beads and tracer in the
presence of various test compounds for 2 h. Non-specific binding was
measured by conducting the reaction in the presence of
MCH peptide. Readings were taken in the top count scintillation
counter. The extent of antagonism was expressed as displacement.
1 lM of cold
17. (a) Mendez-Andino, J. L.; Wos, J. A. Drug Discovery Today 2007, 12, 972; (b)
McBriar, M. D.; Guzik, H.; Shapiro, S.; Paruchova, J.; Xu, R.; Palani, A.; Clader, J.
W.; Cox, K.; Greenlee, W. J.; Hawes, B. E.; Kowalski, T. J.; O’Neill, K.; Spar, B. D.;
Weig, B.; Weston, D. J.; Farley, C.; Cook, J. Journal Med. Chem. 2006, 49, 2294.
18. Andersen, D.; Storz, T.; Liu, P. L.; Wang, X.; Li, L. P.; Fan, P. C.; Chen, X. Q.;
Allgeier, A.; Burgos, A.; Tedrow, J.; Baum, J.; Chen, Y.; Crockett, R.; Huang, L.;
Syed, R.; Larsen, R. D.; Martinelli, M. Journal Org. Chem. 2007, 72, 9648.
19. (a) Rokosz, L. L. Exp. Opin. Drug Discovery 2007, 2, 1301; (b) Liu, Y.; Sprenger, K.;
Maynard, G.; Friedman, H.; Anciro, L.; Rajachandran, L.; Changchit, A. J. Clin.
Pharmacol. 2009, 49, 1101.
20. (a) Receveur, J.-M.; Bjurling, E.; Ulven, T.; Little, P. B.; Nørregaard, P. K.;
Högberg, T. Bioorg. Med. Chem. Lett. 2004, 14, 5075; (b) Ulven, T.; Frimurer, T.
M.; Receveur, J.-M.; Little, P. B.; Rist, Ø.; Nørregaard, P.; Högberg, T. Journal Med.
Chem. 2005, 48, 5684; (c) Ulven, T.; Little, P. B.; Receveur, J.-M.; Frimurer, T. M.;
Rist, Ø.; Nørregaard, P.; Högberg, T. Bioorg. Med. Chem. Lett. 2006, 16, 1070.
21. Iemura, R.; Kawashima, T.; Fukuda, T.; Ito, K.; Tsukamoto, G. Journal Med. Chem.
1986, 29, 1178.
%
The IC50 for the compound was calculated by graph pad prism software
using the average CPM values
34. Functional response of compounds was assessed using the IP3-SPA-YSI
method. Briefly, CHO-K1 cells stably expressing hMCHR1 were incubated
overnight with 0.5 lCi/well of 3H-myo-inositol to generate a pool of 3H-PIP2.
After aspiration of labeling medium, the cells were incubated with test
compounds followed by stimulation with 80 nM of agonist (MCH peptide). The
resulting pool of 3H-IPs was extracted with formic acid and the amount of 3H-
IPs generated in the cells was detected using the non-derivatized yttrium
silicate SPA beads.
35. Generic numbering of amino acids in TM bundle according to: Schwartz, T. W.
Curr. Opin. Biotechnol. 1994, 5, 434.
36. C57BL/6J mice were fed a high fat diet (60% calories from fat, D12492 feed) for
nearly 3 months until they reached an average body weight of approximately
45 g. Animals were grouped based on initial body weight. Compounds to be
tested were then administered per orally twice daily for a period of 7 days.
Body weight and food intake of the animals was recorded on a daily basis
during the experimental duration.
22. Lavrado, J.; Paulo, A.; Gut, J.; Rosenthal, P. J.; Moreira, R. Bioorg. Med. Chem. Lett.
2008, 18, 1378.